Enter assignee name

EPO Patents = 1

Forward Citations = 20

where 'Filed Patents' based on already Granted Patents

where 'Inventors Filed' based on already Granted Patents

3 inventors (with patents filed for the assignee):

Yi Heng Chen (16 out of 77 patents)

Yan Lou (11 out of 74 patents)

Xiang Li (14 patents)

16 patents: Sort by Forward Citations

1. 12410190 - Condensed heterocyclic derivates as BCL-2 inhibitors for the treatment of neoplastic diseases (2025-09-09),

2. 12220419 - BCL-2 inhibitors (2025-02-11),

3. 12086788 - Substituted pyrazines as inhibitors of BTK, and mutants thereof (2024-09-10),

4. 11993610 - BCL-2 inhibitors (2024-05-28),

5. 11903950 - BCL-2 inhibitors (2024-02-20),

6. 11680072 - Condensed heterocyclic derivates as BCL-2 inhibitors for the treatment of neoplastic diseases (2023-06-20),

7. 11501284 - Substituted pyrazines as inhibitors of BTK, and mutants thereof (2022-11-15),

8. 11479555 - Substituted 1,2-dihydro-3H-pyrazolo[3,4-D]pyrimidin-3-ones as inhibitors of WEE-1 kinase (2022-10-25),

9. 11365206 - BCL-2 inhibitors (2022-06-21),

10. 11279711 - Condensed heterocyclic derivates as BCL-2 inhibitors for the treatment of neoplastic diseases (2022-03-22),

11. 10501456 - Therapeutic agents for the treatment of HBV infection (2019-12-10),

12. 10456397 - Covalent inhibitors of CDK-7 (2019-10-29),

13. 10377755 - BCL-2 inhibitors (2019-08-13),

14. 10253029 - Dual-warhead covalent inhibitors of FGFR-4 (2019-04-09),

15. 10239872 - Therapeutic agents for the treatment of HBV infection (2019-03-26),

Newave Pharmaceutical Inc. is a leading pharmaceutical company focused on research, development, and manufacturing of innovative healthcare solutions. With a strong commitment to quality and customer satisfaction, Newave Pharmaceutical Inc. aims to improve the well-being of individuals and communities worldwide. Through cutting-edge technology, state-of-the-art facilities, and a team of highly skilled professionals, they deliver efficient and safe pharmaceutical products. Visit their website to learn more about their wide range of offerings and their dedication towards advancing global health.

This text is generated by artificial intelligence and may not be accurate.

Company Badge

USPTO Data Jan 1 1976 - Dec 2 2025

16 Patents

#35 in Pleasanton, CA

#4,620 in California

#19,268 in US

#36,630 in the World

Pleasanton, CA, United States of America

Newave Pharmaceutical Inc.

Forward Citations = 20

3 inventors:

Yi Heng Chen (16 out of 77 patents)

Yan Lou (11 out of 74 patents)

Xiang Li (14 patents)

Please report any incorrect information to support@idiyas.com